Materialise NV

Materialise NV

MTLS · NASDAQ · Technology / Software - Application

6.49USD-0.10 (-1.52%)

Price History

Full chart

Market Stats

Previous Close6.59
Open6.60
Day Range6.46 – 6.65
52-Week Range4.78 – 8.61
Volume57.62K
Market Cap486.51M
P/E (TTM)32.42
Forward P/E625.00
EPS0.26
Dividend Yield0.00%
Beta1.36
50-Day Avg6.98
200-Day Avg6.05

About

Materialise NV provides additive manufacturing and medical software tools, and 3D printing services in the Americas, Europe, Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers proprietary software through programs and platforms that enable and enhance the functionality of 3D printers, and printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners; a MES, software providers. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, website, and third-party distributors. The Materialise Medical segment provides medical software that allows medical-image based analysis, planning, and engineering, as well as patient-specific design and printing of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies. The Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to customers serving the automotive, consumer goods industrial goods, semiconductor, art and architecture and aerospace markets. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Smith & Nephew Inc.; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.

Company Details

  • SectorTechnology
  • IndustrySoftware - Application
  • CEOMs. Brigitte de Vet-Veithen
  • Employees2.56K
  • HeadquartersTechnologielaan 15, Leuven, Belgium, 3001, USA
  • Websitehttps://www.materialise.com

Leadership

  • Mr. Wilfried VancraenFounder & Chairman · b. 1962
  • Ms. Brigitte de Vet-VeithenChief Executive Officer · b. 1972
  • Mr. Koen BergesChief Financial Officer · b. 1976
  • Mr. Johan PauwelsExecutive VP & COO · b. 1968
  • Mr. Bart Van der SchuerenChief Strategy & Technology Officer and Executive VP · b. 1968
  • Ms. Carla Van SteenbergenExecutive Vice President, Director of Corporate Affairs, Compliance Officer & Secretary · b. 1977
  • Mr. Jurgen LaudusExecutive Vice President of Manufacturing · b. 1979
  • Mr. Udo EberleinExecutive Vice President of Software · b. 1969

Financials

Income Statement

Currency: EUR2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue59.11M68.72M81.36M102.03M114.48M142.57M184.72M196.68M170.45M205.45M232.02M256.13M266.76M257.07M
Growth (%)-+16.27%+18.38%+25.42%+12.19%+24.54%+29.56%+6.47%-13.34%+20.53%+12.93%+10.39%+4.15%-3.63%
Cost of Revenue23.79M27.19M32.40M42.96M46.71M62.79M82.30M87.05M76.45M87.28M103.25M111.00M115.94M110.16M
Gross Profit35.31M41.53M48.96M59.07M67.77M79.79M102.42M109.63M94.00M118.17M128.77M145.13M150.82M146.91M
Gross Margin59.75%60.44%60.18%57.89%59.20%55.96%55.45%55.74%55.15%57.52%55.50%56.66%56.54%57.15%
Operating Expense33.24M37.11M48.63M62.96M67.66M79.39M97.26M102.69M98.64M105.95M131.64M139.51M141.39M141.97M
Operating Income2.08M4.42M330.00K-3.89M107.00K392.00K5.16M6.94M-4.64M12.22M-2.87M5.62M9.43M4.94M
Operating Margin3.52%6.43%0.41%-3.81%0.09%0.27%2.80%3.53%-2.72%5.95%-1.24%2.19%3.54%1.92%
EBITDA5.12M7.19M7.43M4.07M7.58M12.18M19.89M19.71M13.75M36.72M23.44M30.09M31.24M25.79M
EBITDA Margin8.66%10.46%9.13%3.99%6.62%8.54%10.77%10.02%8.07%17.87%10.10%11.75%11.71%10.03%
Net Income1.55M3.51M2.06M-2.81M-3.02M-2.12M3.03M1.59M-7.04M13.15M-2.12M6.72M13.44M7.41M
Net Income Margin2.62%5.11%2.53%-2.75%-2.64%-1.48%1.64%0.81%-4.13%6.40%-0.91%2.62%5.04%2.88%
R&D9.42M10.60M15.09M18.19M17.68M19.96M22.42M23.35M27.10M26.89M37.57M38.10M44.40M44.27M
R&D as % of Total Revenue15.94%15.42%18.55%17.82%15.45%14.00%12.14%11.87%15.90%13.09%16.19%14.87%16.64%17.22%
Interest Expense601.33K568.00K606.00K615.00K665.00K1.03M4.86M3.19M3.42M3.36M2.92M2.09M1.65M5.39M
Interest Expense % of Total Revenue1.02%0.83%0.74%0.60%0.58%0.72%2.63%1.62%2.00%1.64%1.26%0.82%0.62%2.10%

Balance Sheet

Currency: EUR2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets38.51M46.67M55.69M133.22M144.14M161.92M237.54M313.23M392.20M398.78M413.41M411.26M396.63M396.34M420.47M
Total Liabilities26.77M33.34M37.95M48.05M61.18M82.89M160.02M177.24M231.93M235.83M180.83M182.33M160.04M147.84M165.09M
Total Equity11.74M13.30M17.73M85.30M82.95M79.03M77.52M135.99M156.60M162.96M232.58M228.96M236.65M248.58M255.45M
Cash2.92M6.42M12.60M51.02M50.73M55.91M43.17M115.51M144.69M136.47M196.03M140.87M127.57M102.30M133.86M
Total Debt11.87M15.67M16.32M17.35M21.09M33.81M94.56M106.04M143.61M140.84M99.11M80.98M64.40M41.28M66.15M
Net Debt8.94M9.26M3.72M-33.67M-29.64M-22.11M51.38M-9.47M-1.08M4.37M-96.92M-59.89M-63.17M-61.02M-67.71M

Cash Flow

Currency: EUR2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow6.11M8.88M4.84M3.67M8.49M9.89M28.32M28.40M29.98M25.84M22.29M20.16M31.46M22.68M
Investing Cash Flow-4.96M-3.30M-31.25M-4.11M-12.64M-59.18M-22.13M-25.62M-28.27M-13.13M-53.86M-11.04M-28.59M-9.32M
Financing Cash Flow2.38M729.00K62.06M-1.79M9.27M38.04M65.23M10.78M-16.89M71.16M-22.51M-22.37M-27.64M18.00M
Capital Expenditure5.05M2.95M10.50M10.55M14.58M32.01M20.11M15.66M17.65M11.72M24.77M11.76M26.38M13.54M
Free Cash Flow1.07M5.93M-5.67M-6.88M-6.08M-22.13M8.21M12.74M12.33M14.12M-2.48M8.40M5.08M9.14M
Dividends Paid---00000000000
FCF to OCF17.45%66.81%-117.07%-187.65%-71.62%-223.82%29.01%44.85%41.12%54.64%-11.15%41.66%16.15%40.31%
Dividend Paid to FCF---0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Earnings

Report DateAug 14, 2014Nov 12, 2014Mar 4, 2015May 13, 2015Aug 11, 2015Nov 13, 2015Mar 2, 2016May 11, 2016Aug 11, 2016Nov 9, 2016Feb 24, 2017May 9, 2017Aug 8, 2017Nov 9, 2017Mar 6, 2018May 4, 2018Aug 7, 2018Oct 31, 2018Mar 6, 2019Apr 30, 2019Aug 6, 2019Oct 31, 2019Mar 4, 2020Apr 30, 2020Jul 30, 2020Oct 29, 2020Mar 9, 2021Apr 29, 2021Jul 29, 2021Oct 28, 2021Mar 3, 2022Apr 28, 2022Jul 28, 2022Oct 27, 2022Feb 14, 2023Apr 27, 2023Jul 26, 2023Oct 26, 2023Feb 21, 2024Apr 25, 2024Jul 31, 2024Oct 24, 2024Feb 20, 2025Apr 24, 2025Jul 24, 2025Oct 28, 2025Feb 19, 2026May 7, 2026Aug 27, 2026Oct 28, 2026
EPS Estimate-0.02-0.01--0.03-0.02-0.01-0.01-0.02-0.01-0.010.00-0.01-0.010.020.010.020.010.040.010.030.020.05-0.02-0.06-0.010.01-0.02-0.020.010.040.010.020.020.02-0.070.050.010.060.030.050.030.05-0.040.020.010.060.010.040.03
EPS Actual-0.010.05-0.01-0.02-0.06-0.020.05-0.07-0.01-0.000.01-0.02-0.02-0.020.04-0.000.010.040.01-0.01-0.010.020.03-0.05-0.04-0.01-0.01-0.060.070.150.080.000.020.02-0.080.06-0.010.07-0.010.060.070.050.05-0.010.010.040.120.030.07-
Surprise71.50%600.00%-33.33%-200.00%-100.00%600.00%-250.00%0.00%-0.00%--100.00%-100.00%100.00%-147.00%-50.00%300.00%-75.00%-200.00%-133.33%0.00%-40.00%-150.00%33.33%0.00%-200.00%-200.00%450.00%1400.00%100.00%-75.00%0.00%0.00%-500.00%185.71%-120.00%600.00%-116.67%100.00%40.00%66.67%0.00%75.00%-50.00%300.00%100.00%200.00%75.00%-
TimingPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-market

Key Statistics & Ratios

Market Cap486.51M
Enterprise Value370.89M
Trailing P/E32.42
Forward P/E625.00
PEG Ratio1.26
Price / Sales1.78
Price / Book1.57
EPS0.26
Book Value5.01
Revenue (TTM)272.77M
Gross Profit (TTM)156.12M
EBITDA26.73M
Profit Margin4.84%
Operating Margin0.61%
Return on Equity5.22%
Return on Assets1.65%
Shares Outstanding57.71M
Shares Float23.04M
Beta1.36
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 2 analystsTarget 8.78
  • Strong Buy
    1
  • Buy
    1

Ownership Breakdown

Institutions
14.25%
Insiders
5.30%
Retail / Other
80.45%

Top Institutional Holders

  • Disciplined Growth Investors Inc
    1.99M3.44%
  • Rock Point Advisors, LLC
    990.87K1.71%
  • Archon Capital Management LLC
    766.62K1.33%
  • King Luther Capital Management Corp
    628.75K1.09%
  • Acadian Asset Management LLC
    552.72K0.96%
  • ARK Investment Management LLC
    444.32K0.77%
  • Wells Fargo & Co
    356.02K0.62%
  • Arrowstreet Capital Limited Partnership
    342.64K0.59%
  • Renaissance Technologies Corp
    304.70K0.53%
  • Citadel Advisors Llc
    246.12K0.43%
  • Morgan Stanley - Brokerage Accounts
    206.35K0.36%
  • Edmond de Rothschild Holding S.A.
    200.01K0.35%
  • Crédit Agricole S.A.
    196.95K0.34%
  • Susquehanna International Group, LLP
    161.31K0.28%
  • Two Sigma Investments LLC
    100.53K0.17%
  • NANO CAP NEW MILLENNIUM GROWTH FUND L P
    100.00K0.17%

Top Fund Holders

  • The 3D Printing ETF
    342.12K0.58%
  • EdR SICAV Tech for Tomorrow CR EUR
    200.08K0.34%
  • Paladin One F
    174.41K0.30%
  • WertArt Capital Fonds AMI I (a)
    90.00K0.15%